Blog - Latest News

Why Hospitals Are Not Buying T2 Biosystems Diagnostic System – $1.50 Price Target

T2 Biosystems’ recent Breakthrough Device designation by the FDA isn’t an acknowledgement of the device’s effectiveness or clinical value proposition, only that it diagnoses life-threatening conditions.

The T2Dx Instrument adds additional hospital expense but provides little clinical value, hence the miniscule sales numbers.

The value of the T2Bacteria test is low because it does not measure bacterial susceptibility to antibiotics and, therefore, d